As of 2020, approximately 600 pharmaceutics companies participated in the Medicaid Drug Rebate Program.
The inflationary rebate as the difference between the AMP on the launch date compared with the current quarter and the United States Consumer Price Index-Urban.
In 1990, only 2.8 million people were enrolled in Medicaid managed care and so the savings lost by the exemption were relatively small.
[3] The Drug Rebate Equalization Act of 2009 (DRE), introduced in the 111th United States Congress by Representative Bart Stupak as H.R.
The Congressional Budget Office scored the DRE as saving $11 billion over ten years.
[5] The DRE passed in both the House and Senate as part of their respective comprehensive health care reform legislation, and was signed into law on March 23, 2010, by President Obama with the Patient Protection and Affordable Care Act.